Highlights of the In Vitro Sections of the Draft ICH Drug Interaction Studies Guideline



January 16, 2024

  • Share
  • Speaker: Brian Ogilvie, PhD, Vice President of Scientific Consulting, BioIVT Abstract: In June 2022, the ICH released the draft of its harmonized Drug Interaction Studies Guideline (M12). The guideline resulted from several meetings of the Expert Working Group since 2018 with the goal of harmonizing member regulatory agencies’ guidelines into one that will be used across all member countries. After review, the guideline will be adopted in 2024. This presentation will describe differences between current in vitro drug-drug interaction guidance from the relevant US FDA, EMA and PMDA guidance documents, and how to plan on meeting the ICH M12 guideline.

    Analytical TechniquesBiopharmaDrug DiscoveryMass Spectrometry

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.